Importance: As US health care systems shift to human papillomavirus (HPV)-based cervical cancer screening, more patients are receiving positive high-risk non-16/18 genotype HPV results and negative for intraepithelial lesion or malignancy (NILM) cytological findings. Risk-based management guidelines recommend 2 consecutive negative annual results to return to routine screening.
Objective: To quantify patterns of surveillance testing and associated outcomes for patients after an HPV-positive results and NILM cytologic findings.
Purpose: Females living with human immunodeficiency virus (FLWHIV) are at increased risk of cervical cancer and U.S. guidelines, first published in 2009 and updated since then, recommend more frequent screening in this population.
View Article and Find Full Text PDFObjectives: We aimed to describe contraceptive methods used by clinicians who counsel adolescents to create an aggregate perspective which could be shared with patients. We also explored which method clinicians would recommend to a hypothetical daughter to identify associations between clinicians who had used long-acting reversible contraception (LARC) and potential recommendations.
Methods: An online survey was sent to pediatric and adolescent gynecology academic societies and fellowship/division directors to share with their clinicians.
Background: Guidelines for managing abnormal cervical cancer screening results are complex and adherence is challenging for clinicians. Previous studies have identified gaps in knowledge as a possible cause; few have explored the confidence clinicians have in their management decisions. Confidence in decision-making may influence management practices, particularly when guidelines are complex and evolving.
View Article and Find Full Text PDF